Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emer P Reeves

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|April 9, 2020
Consequences of Abrupt Cessation of Alpha<sub>1</sub>-Antitrypsin Replacement TherapyOliver J McElvaney, Tomás P Carroll, Alessandro N Franciosi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosisEmer P Reeves, Michael Williamson, Barry Byrne, et al.
COPD|May 5, 2015
The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare diseaseM Emmet O'Brien, Kevin Pennycooke, Tomás P Carroll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2015
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil SignalingCiara A O'Dwyer, M Emmet O'Brien, Mark R Wormald, et al.
American Journal of Respiratory and Critical Care Medicine|November 17, 2017
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired PneumoniaCormac McCarthy, Danielle M Dunlea, Radka Saldova, et al.
Cell Reports|March 15, 2018
Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial KillingDanielle M Clancy, Graeme P Sullivan, Hannah B T Moran, et al.
World Journal of Critical Care Medicine|August 12, 2015
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and functionEmer P Reeves, Cormac McCarthy, Oliver J McElvaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individualsKillian Hurley, Noreen Lacey, Ciara A O'Dwyer, et al.
International Journal of Molecular Sciences|March 10, 2022
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic ApplicationMichael E O'Brien, Grace Murray, Debananda Gogoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lungIsabel Vega-Carrascal, David A Bergin, Oliver J McElvaney, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|April 9, 2020
Consequences of Abrupt Cessation of Alpha<sub>1</sub>-Antitrypsin Replacement TherapyOliver J McElvaney, Tomás P Carroll, Alessandro N Franciosi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2009
IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosisEmer P Reeves, Michael Williamson, Barry Byrne, et al.
COPD|May 5, 2015
The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare diseaseM Emmet O'Brien, Kevin Pennycooke, Tomás P Carroll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2015
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil SignalingCiara A O'Dwyer, M Emmet O'Brien, Mark R Wormald, et al.
American Journal of Respiratory and Critical Care Medicine|November 17, 2017
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired PneumoniaCormac McCarthy, Danielle M Dunlea, Radka Saldova, et al.
Cell Reports|March 15, 2018
Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial KillingDanielle M Clancy, Graeme P Sullivan, Hannah B T Moran, et al.
World Journal of Critical Care Medicine|August 12, 2015
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and functionEmer P Reeves, Cormac McCarthy, Oliver J McElvaney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2014
Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individualsKillian Hurley, Noreen Lacey, Ciara A O'Dwyer, et al.
International Journal of Molecular Sciences|March 10, 2022
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic ApplicationMichael E O'Brien, Grace Murray, Debananda Gogoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2014
Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lungIsabel Vega-Carrascal, David A Bergin, Oliver J McElvaney, et al.
Pageof 9